Total Payments
$18,196
2024 Payments
$1,660
Companies
56
Transactions
505
Medicare Patients
1,226
Medicare Billing
$59,690
Payment Breakdown by Category
Food & Beverage$11,468 (63.0%)
Other$3,485 (19.2%)
Consulting$2,093 (11.5%)
Travel$720.78 (4.0%)
Education$429.67 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,468 | 484 | 63.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,485 | 6 | 19.2% |
| Consulting Fee | $2,093 | 6 | 11.5% |
| Travel and Lodging | $720.78 | 5 | 4.0% |
| Education | $429.67 | 4 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $7,419 | 41 | $0 (2024) |
| Amgen Inc. | $877.40 | 34 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $800.62 | 20 | $0 (2024) |
| Incyte Corporation | $734.15 | 34 | $0 (2024) |
| Seagen Inc. | $647.23 | 27 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $537.41 | 28 | $0 (2024) |
| Merck Sharp & Dohme LLC | $502.42 | 27 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $498.20 | 34 | $0 (2024) |
| Janssen Biotech, Inc. | $495.88 | 26 | $0 (2024) |
| Rigel Pharmaceuticals, Inc. | $431.04 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,660 | 46 | Gilead Sciences, Inc. ($267.61) |
| 2023 | $1,364 | 44 | Amgen Inc. ($165.41) |
| 2022 | $7,662 | 250 | EISAI INC. ($2,642) |
| 2021 | $7,509 | 165 | Eisai Inc. ($4,721) |
All Payment Transactions
505 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $22.42 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Immunology | ||||||
| 10/10/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $14.94 | General |
| 10/08/2024 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $122.50 | General |
| 10/03/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: HORMONE THERAPY | ||||||
| 09/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Diagnostic Imaging | ||||||
| 09/05/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: ONC | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: Oncology | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Oncology | ||||||
| 08/19/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Oncology | ||||||
| 07/12/2024 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $26.46 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 06/27/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: HEMATOLOGY | ||||||
| 06/25/2024 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: Oncology | ||||||
| 06/24/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: ONCOLOGY | ||||||
| 06/19/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $21.86 | General |
| Category: Oncology | ||||||
| 06/13/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Oncology | ||||||
| 06/04/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Hematology/Oncology | ||||||
| 06/04/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $8.70 | General |
| Category: Oncology | ||||||
| 06/04/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $0.14 | General |
| Category: Oncology | ||||||
| 05/23/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $17.24 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 178 | 194 | $15,204 | $6,009 |
| 2022 | 5 | 442 | 521 | $45,479 | $23,108 |
| 2021 | 7 | 423 | 472 | $32,866 | $15,434 |
| 2020 | 3 | 183 | 205 | $43,240 | $15,139 |
Total Patients
1,226
Total Services
1,392
Medicare Billing
$59,690
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 66 | $9,683 | $3,702 | 38.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $2,548 | $1,355 | 53.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 72 | 80 | $1,840 | $608.80 | 33.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 20 | 22 | $704.00 | $227.70 | 32.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 13 | $429.00 | $115.44 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 169 | 189 | $27,594 | $14,670 | 53.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 49 | $9,604 | $5,550 | 57.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 192 | 235 | $5,405 | $1,788 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 20 | $1,980 | $807.80 | 40.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 25 | 28 | $896.00 | $293.56 | 32.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 81 | $8,019 | $4,544 | 56.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 54 | $7,884 | $4,528 | 57.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 31 | $6,076 | $3,673 | 60.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 120 | 137 | $5,878 | $1,437 | 24.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 128 | 145 | $4,505 | $1,119 | 24.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 12 | $396.00 | $92.10 | 23.3% |
| 81002 | Urinalysis, manual test | Office | 2021 | 11 | 12 | $108.00 | $41.76 | 38.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 123 | 139 | $28,078 | $9,855 | 35.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 40 | 45 | $12,285 | $4,315 | 35.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 20 | 21 | $2,877 | $968.24 | 33.7% |
About Tracey Hoffman, NP
Tracey Hoffman, NP is a Nurse Practitioner healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/18/2010. The National Provider Identifier (NPI) number assigned to this provider is 1306148671.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tracey Hoffman, NP has received a total of $18,196 in payments from pharmaceutical and medical device companies, with $1,660 received in 2024. These payments were reported across 505 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($11,468).
As a Medicare-enrolled provider, Hoffman has provided services to 1,226 Medicare beneficiaries, totaling 1,392 services with total Medicare billing of $59,690. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family, Family
- Location Louisville, KY
- Active Since 11/18/2010
- Last Updated 12/06/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1306148671
Products in Payments
- Lenvima (Drug) $7,419
- JAKAFI (Drug) $587.26
- KEYTRUDA (Biological) $483.44
- OPDIVO (Biological) $422.53
- Tavalisse (Drug) $413.26
- TAGRISSO (Drug) $392.18
- Udenyca (Biological) $342.95
- LIBTAYO (Biological) $318.49
- Trodelvy (Drug) $303.95
- IMFINZI (Biological) $252.15
- LUMAKRAS (Drug) $235.64
- PADCEV (Biological) $226.51
- Nplate (Biological) $220.17
- TUKYSA (Drug) $217.37
- IMBRUVICA (Drug) $195.21
- MONJUVI (Drug) $191.02
- BRUKINSA (Drug) $175.20
- VENCLEXTA (Drug) $158.62
- ICLUSIG (Drug) $151.12
- IBRANCE (Drug) $149.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Louisville
Mrs. Tara Mudd, Msn, Aprn, Np-C, MSN, APRN, NP-C
Nurse Practitioner — Payments: $189,065
Nurse Practitioner $189,065
Ms. Stephanie Flaspoehler, Arnp, ARNP
Nurse Practitioner — Payments: $117,111
Nurse Practitioner $117,111
Christina Benninger, Aprn, APRN
Nurse Practitioner — Payments: $81,280
Nurse Practitioner $81,280
Lee Haas, Fnp, FNP
Nurse Practitioner — Payments: $58,919
Nurse Practitioner $58,919
Mrs. Christin Thompson, Aprn, APRN
Nurse Practitioner — Payments: $37,707
Nurse Practitioner $37,707
Rebecca Brauner, Arnp, ARNP
Nurse Practitioner — Payments: $32,529
Nurse Practitioner $32,529